Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ Phase 3 trial of daridorexant in South Korea met both…
Rigel Pharma (RIGL) Earnings Call Transcript
Tuesday, March 3, 2026 at 4:30 p.m. ET Chief Executive Officer — Raul R. Rodriguez Chief Commercial Officer — David A. Santos Chief Medical Officer — Lisa Rojkjaer Chief Financial Officer — Dean L. Schorno Need a quote…
Ascendis Pharma: Yuviwel Approved Despite Legal Challenges (NASDAQ:ASND)
Yuviwel is expected to add only modestly to 2024 revenues, with $30–40 million in 2026 net sales seen as a reasonable target given limited U.S. market penetration. The Yuviwel plus Skytrofa combination, showing much higher efficacy than…
Natco Pharma launches generic of cancer drug in U.S.
Natco Pharma along with its partner Breckenridge Pharmaceutical Inc has launched Pomalidomide Capsules, a generic version of Celgene's Pomalyst in the U.S. market. A thalidomide analogue, the product is indicated for the treatment of multiple…
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Strong-Buy at Jefferies Financial Group
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by investment analysts at Jefferies Financial Group to a 'strong-buy' rating in a note issued to investors on Tuesday, Marketbeat Ratings reports. Several other equities research analysts…
Over 30 stocks including Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla, Juniper Hotels will hog limelight
Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company's Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5…
Aisling Capital Management LP Has $316.29 Million Position in BridgeBio Pharma, Inc. $BBIO
Aisling Capital Management LP raised its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 0.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
TD Asset Management Inc Acquires 91,136 Shares of Royalty Pharma PLC $RPRX
TD Asset Management Inc raised its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 88.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 194,202 shares of the…
Furoscix Growth Vs. Tyvaso Royalties: Assessing MannKind's Future (NASDAQ:MNKD)
MannKind Corporation faces strategic risk after United Therapeutics announced plans for a soft-mist treprostinil inhaler, threatening Tyvaso DPI royalties. MNKD's FY25 revenue grew 22% to $349M, driven by product expansion, royalties, and the…
Stock Market Turbulence: How to Invest Wisely and Safely Right Now
The S&P 500 faced headwinds on occasion over the past three years, but it still offered investors a solid path upward, gaining 78%. This happened amid optimism about the growth potential of artificial intelligence (AI) stocks as well as optimism…
Trump's Prescription Drugs Policy Has Worked
Let's bank the win rather than let Big Pharma bankroll a win for themselves. Heading into this year's midterms, Republicans are jittery. There is particular concern that Democrats could hold over our collective heads the failure to extend…
Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Agilent Technologies, Inc. (A) TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM EST Adam Elinoff - Senior VP, CFO & Principal Financial Officer Tejas Savant - Vice President of Investor Relations Daniel Brennan - TD Cowen…
FDA sends warning to 30 telehealth companies selling 'illegal' GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the sale of these unapproved…
Revvity, Inc. (RVTY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Revvity, Inc. (RVTY) TD Cowen 46th Annual Health Care Conference March 3, 2026 2:30 PM EST Prahlad Singh - CEO, President & Director Daniel Brennan - TD Cowen, Research Division All right. Terrific. Welcome, day 2 of the TD Cowen Global Healthcare…
Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Danaher Corporation (DHR) TD Cowen 46th Annual Health Care Conference March 3, 2026 1:50 PM EST Rainer Blair - President, CEO & Director Daniel Brennan - TD Cowen, Research Division Terrific. Well, welcome. Day 2 of the TD Cowen Global Healthcare…
Receive a Daily briefing on Pharma Industry News
Get Started